Arcadia Biosciences, Inc. (RKDA) Financial Statements (2024 and earlier)

Company Profile

Business Address 202 COUSTEAU PLACE
DAVIS, 95618
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 01 - Agricultural Production Crops (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments20,64428,68525,66725,33221,82313,023
Cash and cash equivalents20,64428,68514,0428,41711,9989,125
Short-term investments  11,62516,9159,8253,898
Receivables (3)1,3701,4066021681,235
Inventory, net of allowances, customer advances and progress billings2,5714,4333,8121,794181229
Inventory2,5714,4333,8121,794181229
Deferred costs    226197 
Disposal group, including discontinued operation      
Asset, held-for-sale, not part of disposal group87     
Other undisclosed current assets2,099900811486507560
Total current assets:25,39835,38831,69628,44022,87615,047
Noncurrent Assets
Inventory, Noncurrent7672,4943,4853647461,168
Operating lease, right-of-use asset1,8483,0815,8261,963
Property, plant and equipment7042,2913,5391,799395299
Intangible assets, net (including goodwill)40484778   
Goodwill   408   
Intangible assets, net (excluding goodwill)40484370   
Restricted cash and investments   2,001   
Other noncurrent assets165180238756
Total noncurrent assets:3,5248,53015,6524,1341,1481,523
TOTAL ASSETS:28,92243,91847,34832,57424,02416,570
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,8813,6384,1054,6852,6452,496
Employee-related liabilities1,6061,4891,2901,096805
Accounts payable 9311,411726492285366
Accrued liabilities 1,746271592598648319
Other undisclosed accounts payable and accrued liabilities2043501,2982,3056161,006
Deferred revenue   842
Debt   1,141635  
Disposal group, including discontinued operation      
Deferred revenue and credits1,000
Due to related parties486480402929
Contract with customer, liability96
Other liabilities 270264263306284 
Other undisclosed current liabilities1,0101,074717   
Total current liabilities:4,2095,0406,3145,7083,0543,525
Noncurrent Liabilities
Long-term debt and lease obligation  2,2207,4941,604  
Long-term debt, excluding current maturities   2,105107  
Liabilities, other than long-term debt3,0072,0702,2802,0003,0725,038
Deferred revenue and credits2,038
Other liabilities2,0002,0702,2802,0003,0723,000
Operating lease, liability1,0072,2205,3891,497
Other undisclosed noncurrent liabilities8063,3922,70814,9365,083 
Total noncurrent liabilities:3,8137,68212,48218,5408,1555,038
Total liabilities:8,02212,72218,79624,24811,2098,563
Equity
Equity, attributable to parent21,03331,09327,7257,70512,8158,007
Common stock656354494542
Additional paid in capital278,827257,515239,496214,826191,136175,223
Accumulated other comprehensive income (loss)   1 (1)
Accumulated deficit(257,859)(226,485)(211,825)(207,171)(178,366)(167,257)
Equity, attributable to noncontrolling interest(133)103827621  
Total equity:20,90031,19628,5528,32612,8158,007
TOTAL LIABILITIES AND EQUITY:28,92243,91847,34832,57424,02416,570

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues9,9566,7808,0341,1691,4644,026
Revenue, net4,026
Cost of revenue(9,802)(13,390)(4,311)(304)(310)(283)
Cost of goods and services sold(9,802)(8,708)(4,311)(304)(310)(283)
Gross profit:154(6,610)3,7238651,1543,743
Operating expenses(19,557)(28,916)(20,812)(20,550)(18,334)(18,341)
Other undisclosed operating income (loss)588 4,311304310283
Operating loss:(18,815)(35,526)(12,778)(19,381)(16,870)(14,315)
Nonoperating income
(Other Nonoperating income)
3310,114740466394281
Interest and debt expense  (20)(682)(5) (1,647)
Loss from continuing operations before equity method investments, income taxes:(18,782)(25,432)(12,720)(18,920)(16,476)(15,681)
Other undisclosed income (loss) from continuing operations before income taxes3,1849,3006,570(9,951)3,006 
Loss from continuing operations before income taxes:(15,598)(16,132)(6,150)(28,871)(13,470)(15,681)
Income tax expense (benefit)(14)(2)124(2)(10)(26)
Loss from continuing operations:(15,612)(16,134)(6,026)(28,873)(13,480)(15,707)
Loss before gain (loss) on sale of properties:(16,134)(6,026)(28,873)(13,480)(15,707)
Loss from discontinued operations      
Other undisclosed net loss      
Net loss:(15,612)(16,134)(6,026)(28,873)(13,480)(15,707)
Net income attributable to noncontrolling interest2361,4741,37168  
Net loss available to common stockholders, diluted:(15,376)(14,660)(4,655)(28,805)(13,480)(15,707)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(15,612)(16,134)(6,026)(28,873)(13,480)(15,707)
Other comprehensive income (loss)  (1)1 18
Comprehensive loss:(15,612)(16,134)(6,027)(28,872)(13,480)(15,689)
Comprehensive income, net of tax, attributable to noncontrolling interest2361,4741,37168  
Comprehensive loss, net of tax, attributable to parent:(15,376)(14,660)(4,656)(28,804)(13,480)(15,689)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: